Pfizer Overview
- Founded
- 1848

- Status
- Public
- Employees
- 79,000

- Stock Symbol
- PFE

- Investments
- 115
- Share Price
- $52.47
- (As of Friday Closing)
Pfizer General Information
Description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
Contact Information
- 235 East 42nd Street
- New York, NY 10017
- United States
Pfizer Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$52.47 | $50.65 | $38.48 - $61.71 | $294B | 5.61B | 28.1M | $4.44 |
Pfizer Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 298,576,284 | 340,426,773 | 255,869,579 | 260,704,914 |
Revenue | 92,367,000 | 81,288,000 | 41,651,000 | 40,905,000 |
EBITDA | 34,076,000 | 30,757,000 | 13,189,000 | 18,424,000 |
Net Income | 24,966,000 | 21,979,000 | 9,159,000 | 16,026,000 |
Total Assets | 183,841,000 | 181,476,000 | 154,229,000 | 167,594,000 |
Total Debt | 35,052,000 | 36,998,000 | 38,274,000 | 50,840,000 |
Pfizer Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Pfizer‘s full profile, request access.
Request a free trialPfizer Comparisons
Industry
00000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialPfizer Competitors (10)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
GlaxoSmithKline | Corporation | Brentford, United Kingdom | 00000 | 000000000 | ||
00000000 | Corporation | Basel, Switzerland | 000000 | 000000000000 | ||
0000 0000000000000 | Corporate Backed or Acquired | Petach Tikva, Israel | 00000 | 00000 | 00000000000 | 00000 |
0000 0000000 | Corporation | Bagsvaerd, Denmark | 00000 | 000000000 | ||
000 000000 | Corporate Backed or Acquired | Monheim, Germany | 0000 | 000000&0 |
Pfizer Patents
Pfizer Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210268095-A1 | Escherichia coli compositions and methods thereof | Pending | 23-Feb-2020 | 0000000000 | |
US-20210246213-A1 | Anti-e-selectin antibodies, compositions and methods of use | Pending | 24-Jan-2020 | 00000000000 | |
CA-3103120-A1 | Chemical compounds | Pending | 20-Dec-2019 | 0000000000 | |
US-20210188829-A1 | Chemical compounds | Pending | 20-Dec-2019 | 000000000 | |
US-20210179716-A1 | Antibodies specific for cd47, pd-l1, and uses thereof | Pending | 17-Dec-2019 | C07K16/2827 |
Pfizer Executive Team (332)
Pfizer Board Members (23)
Name | Representing | Role | Since |
---|---|---|---|
000000 000000 00.0 | Pfizer | Chief Executive Officer & Chairman | 000 0000 |
000 0000000 00.0 | Pfizer | Board Member | 000 0000 |
00000 0000000 | Pfizer | Director, Portfolio Director & Planning Lead, PMP, Pfizer Oncology | 000 0000 |
00000 00000 00.0 | Pfizer | Board Member | 000 0000 |
00000 00000 | Self | Board Member | 000 0000 |
Pfizer Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPfizer Investments & Acquisitions (115)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 0000 | 10-May-2022 | 0000000000 | 000.00 | Drug Discovery | 0000 0000 |
00000 | 02-May-2022 | 0000 | 00000 | Outcome Management (Healthcare) | |
00000000 0000 | 28-Apr-2022 | 0000 | 0000 | Drug Discovery | 00000 000 |
0000000 | 07-Apr-2022 | 0000000000 | 00000 | Drug Discovery | 000000 00 |
Arena Pharmaceuticals | 11-Mar-2022 | Merger/Acquisition | 00.00 | Drug Discovery | 0000 0000 |
Pfizer Subsidiaries (18)
Company Name | Industry | Location | Founded |
---|---|---|---|
InnoPharma | Pharmaceuticals | Piscataway Township, NJ | 2005 |
0000000 000(0) 000 | Corporate Pension | Peapack, NJ | 0000 |
000000 00000000 | Corporate Venture Capital | New York, NY | 0000 |
00000 000000000 | Biotechnology | Boulder, CO | 0000 |
0000000 000000 000 | Personal Products | Guangzhou, China | 0000 |
Pfizer Exits (30)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000000 | 29-Oct-2020 | 00000 00000 00 | 00000 | Completed |
|
0000000 0000000000 | 01-Nov-2017 | 000000000 | 00000 | Completed |
|
00 000000 00000000 | 13-Dec-2016 | 000000000 | Completed |
|
|
0000000 00000000 | 27-Oct-2016 | 000 | 00000 | Completed |
|
Gemphire Therapeutics | 04-Aug-2016 | IPO | 0000 | Completed |
|